Variations in the content of satellite III (1q12) and ribosomal repeat in the DNA of blood leukocytes of children with autism spectrum disorders during therapy
Authors
E.S. Ershova
Federal State Budgetary Scientific Institution “Medical and Genetic Research Center named after Academician N.P. Bochkov”, Moscow, Russian Federation
Yu.M. Chudakova
Federal State Budgetary Scientific Institution “Medical and Genetic Research Center named after Academician N.P. Bochkov”, Moscow, Russian Federation
N.N. Veiko
Federal State Budgetary Scientific Institution “Medical and Genetic Research Center named after Academician N.P. Bochkov”, Moscow, Russian Federation
A.V. Martynov
Federal State Budgetary Scientific Institution “Medical and Genetic Research Center named after Academician N.P. Bochkov”, Moscow, Russian Federation
S.E. Kostyuk
Federal State Budgetary Scientific Institution “Medical and Genetic Research Center named after Academician N.P. Bochkov”, Moscow, Russian Federation
S.V. Kostyuk
Federal State Budgetary Scientific Institution “Medical and Genetic Research Center named after Academician N.P. Bochkov”, Moscow, Russian Federation
E.E. Balakireva
Federal State Budgetary Scientific Institution “Mental Health Research Center”, Russian Academy of Sciences, Moscow, Russian Federation
O.V. Shushpanova
Federal State Budgetary Scientific Institution “Mental Health Research Center”, Russian Academy of Sciences, Moscow, Russian Federation
S.G. Nikitina
Federal State Budgetary Scientific Institution “Mental Health Research Center”, Russian Academy of Sciences, Moscow, Russian Federation
T.E. Blinova
Federal State Budgetary Scientific Institution “Mental Health Research Center”, Russian Academy of Sciences, Moscow, Russian Federation
N.S. Shalina
Federal State Budgetary Scientific Institution “Mental Health Research Center”, Russian Academy of Sciences, Moscow, Russian Federation
A.A. Koval-Zaitsev
Federal State Budgetary Scientific Institution “Mental Health Research Center”, Russian Academy of Sciences, Moscow, Russian Federation
M.V. Ivanov
Federal State Budgetary Scientific Institution “Mental Health Research Center”, Russian Academy of Sciences, Moscow, Russian Federation
https://doi.org/10.26617/1810-3111-2024-4(125)-17-26
Journal: Siberian Herald of Psychiatry and Addiction Psychiatry. 2024; 4 (125): 17-26.
Abstract
Background. It is known that exacerbation of chronic mental diseases is accompanied by a high level of psy-choemotional stress, and is also associated with activation of nonspecific inflammation and increased oxidative stress. Children with ASD are more susceptible to the adverse effects of stress than average children due to the high level of comorbidity of ASD with other disorders. Earlier studies described the relationship between oxidative stress and repetitive DNA sequences (repeats) that make up a major part of the human genome. The content of satellite III (1q12) in the genomes of children with ASD and the effect of therapy on this parameter have not been determined. In this study, the amount of ribosomal repeat and satellite III (1q12) in the DNA of blood leukocytes of children with ASD who sought help at the Department of Child Psychiatry due to worsening their mental state (increasing concomitant behavioral and/or mood disorders) was established for the first time. The effect of the therapy on the content of these repeats was analyzed. Objective: to analyze the content of genomic repeats (ribosomal, satellite III ‒ 1q12) in DNA samples of blood leukocytes of children with ASD and concomitant disorders in the acute stage in order to analyze the effect of the therapy on the content of these repeats. Patients and Methods. The main study group included 35 children aged 4 to 12 years (mean age 7.2±2.2 years) with the main diagnosis according to ICD-10: childhood autism (F84.0), atypical autism (F84.1) and with a concomitant diagnosis of other anxiety disorders (F41), reaction to severe stress, and adjustment disorders (F43), unspecified mental retardation with significant impairment of behaviour requiring attention or treatment (F7x.1), mixed disorders of conduct and emotions (F92). The control group consisted of 91 children and 100 adults. Patients were selected using the clinical and psychopathological method. Venous blood samples were taken: sample 1 ‒ DNA samples of children before the start of new therapy, samples 2, 3 and 4 ‒ DNA samples obtained by week 2, 4 and 6 of the therapy. DNA was isolated by extraction with organic solvents. The content of three repeats in DNA was determined by non-radioactive quantitative hybridization. The data were analyzed using the StatPlus2007 Professional software, MedCalc, Excel Microsoft Office, StatGraph. Results. DNA samples of children with ASD did not differ in the content of ribosomal repeats from the control group of children of the same age. The content of satellite III varied significantly in most patients during therapy: it increased by 1.1-2 times in 18 patients (51%), decreased by 1.1-4.3 times in 12 patients (34%), and did not change in 5 patients. The content of the satellite increased in case of an initially low repeat level and decreased in case of an initially high level. In sample 4, the distribution for S values was virtually identical to the control distribution. Conclusion. Irrespective from the initial values, under antipsychotic therapy, the content of satellite III (1q12) in the blood of children with ASD and exacerbation of concomitant symptoms stabilize at the level of the control group. These changes are likely associated with an improvement in mental state and a decrease in the overall stress level. The R parameter (ribosomal repeat) did not change throughout this study.
Keywords: autism spectrum disorders, children, content variations, satellite III (1q12), ribosomal repeat, blood leukocyte DNA, psychopharmacotherapy.
Contacts
This email address is being protected from spambots. You need JavaScript enabled to view it.
Materials
For citation: Ershova E.S., Chudakova Yu.M., Veiko N.N., Martynov A.V., Kostyuk S.E., Kostyuk S.V., Balakireva E.E., Shushpanova O.V., Nikitina S.G., Blinova T.E., Shalina N.S., Koval-Zaitsev A.A., Ivanov M.V. Variations in the content of satellite III (1q12) and ribosomal repeat in the DNA of blood leukocytes of children with autism spectrum disorders during therapy. Siberian Herald of Psychiatry and Addiction Psychiatry.2024; 4 (125): 17-26. https://doi.org/10.26617/1810-3111-2024-4(125)-17-26
REFERENCES
- Ghaemi Kerahrodi J, Michal M. The fear-defense system, emotions, and oxidative stress. Redox Biol. 2020 Oct;37:101588. doi: 10.1016/j.redox.2020.101588. Epub 2020 Jul 17. PMID: 32739155; PMCID: PMC7767737.
- Ogawa S, Lee YA, Yamaguchi Y, Shibata Y, Goto Y. Associations of acute and chronic stress hormones with cognitive functions in autism spectrum disorder. Neuroscience. 2017 Feb 20;343:229-239. doi: 10.1016/j.neuroscience.2016.12.003. Epub 2016 Dec 10. PMID: 27956063.
- de Koning AP, Gu W, Castoe TA, Batzer MA, Pollock DD. Repetitive elements may comprise over two-thirds of the human genome. PLoS Genet. 2011 Dec;7(12):e1002384. doi: 10.1371/journal.pgen.1002384. Epub 2011 Dec 1. PMID: 22144907; PMCID: PMC3228813.
- Warburton PE, Hasson D, Guillem F, Lescale C, Jin X, Abrusan G. Analysis of the largest tandemly repeated DNA families in the human genome. BMC Genomics. 2008 Nov 7;9:533. doi: 10.1186/1471-2164-9-533. PMID: 18992157; PMCID: PMC2588610.
- Ershova ES, Malinovskaya EM, Golimbet VE, Lezheiko TV, Zakharova NV, Shmarina GV, Veiko RV, Umriukhin PE, Kostyuk GP, Kutsev SI, Izhevskaya VL, Veiko NN, Kostyuk SV. Copy number variations of satellite III (1q12) and ribosomal repeats in health and schizophrenia. Schizophr Res. 2020 Sep;223:199-212. doi: 10.1016/j.schres.2020.07.022. Epub 2020 Aug 6. PMID: 32773342.
- Hall AN, Morton E, Queitsch C. First discovered, long out of sight, finally visible: ribosomal DNA. Trends Genet. 2022 Jun;38(6):587-597. doi: 10.1016/j.tig.2022.02.005. PMID: 35272860; PMCID: PMC10132741.
- Enukashvily NI, Donev R, Waisertreiger IS, Podgornaya OI. Human chromosome 1 satellite 3 DNA is decondensed, demethylated and transcribed in senescent cells and in A431 epithelial carcinoma cells. Cytogenet Genome Res. 2007;118(1):42-54. doi: 10.1159/000106440. PMID: 17901699.
- Bersani F, Lee E, Kharchenko PV, Xu AW, Liu M, Xega K, MacKenzie OC, Brannigan BW, Wittner BS, Jung H, Ramaswamy S, Park PJ, Maheswaran S, Ting DT, Haber DA. Pericentromeric satellite repeat expansions through RNA-derived DNA intermediates in cancer. Proc Natl Acad Sci U S A. 2015 Dec 8;112(49):15148-53. doi: 10.1073/pnas.1518008112.
- Ershova ES, Agafonova ON, Zakharova NV, Bravve LV, Jestkova EM, Golimbet VE, Lezheiko TV, Morozova AY, Martynov AV, Veiko RV, Umriukhin PE, Kostyuk GP, Kutsev SI, Veiko NN, Kostyuk SV. Copy number variation of satellite Ⅲ(1q12) in patients with schizophrenia. Front Genet. 2019 Nov 22;10:1132. doi: 10.3389/fgene.2019.01132. PMID: 31850056; PMCID: PMC6902095.
- Method for differential diagnostics of childhood schizophrenia and childhood autism by the number of copies of genes encoding ribosomal RNA in the genome of a child with mental disorders. Patent for invention RU 2816043 C1, 26.03.2024 (in Russian).
- Schopler E, Reichler RJ, DeVellis RF, Daly K. Toward objective classification of childhood autism: Childhood Autism Rating Scale (CARS). J Autism Dev Disord. 1980 Mar;10(1):91-103. doi: 10.1007/BF02408436. PMID: 6927682.
- Schopler E, Lansing M, Reichler R, Marcus L. Psychoeducational profile: TEACCH Individualized Psychoeducational Assessment for Children with Autism Spectrum Disorders. Third edition (PEP-3). Austin, TX: Pro-Ed, 2005.
- Ershova ES, Jestkova EM, Martynov AV, Shmarina GV, Umriukhin PE, Bravve LV, Zakharova NV, Kostyuk GP, Saveliev DV, Orlova MD, Bogush M, Kutsev SI, Veiko NN, Kostyuk SV. Accumulation of Circulating Cell-Free CpG-Enriched Ribosomal DNA Fragments on the Background of High Endonuclease Activity of Blood Plasma in Schizophrenic Patients. Int J Genomics. 2019 Aug 5;2019:8390585. doi: 10.1155/2019/8390585. PMID: 31467866; PMCID: PMC6701307.
- Ershova ES, Malinovskaya EM, Konkova MS, Veiko RV, Umriukhin PE, Martynov AV, Kutsev SI, Veiko NN, Kostyuk SV. Copy Number Variation of Human Satellite III (1q12) With Aging. Front Genet. 2019 Aug 7;10:704. doi: 10.3389/fgene.2019.00704. PMID: 31447880; PMCID: PMC6692473.
- Cooke HJ, Hindley J. Cloning of human satellite III DNA: different components are on different chromosomes. Nucleic Acids Res. 1979 Jul 25;6(10):3177-97. doi: 10.1093/nar/6.10.3177. PMID: 573470; PMCID: PMC327928.
- Chestkov IV, Jestkova EM, Ershova ES, Golimbet VE, Lezheiko TV, Kolesina NY, Porokhovnik LN, Lyapunova NA, Izhevskaya VL, Kutsev SI, Veiko NN, Kostyuk SV. Abundance of ribosomal RNA gene copies in the genomes of schizophrenia patients. Schizophr Res. 2018 Jul;197:305-314. doi: 10.1016/j.schres.2018.01.001. Epub 2018 Jan 12. PMID: 29336872.
- Hall AN, Turner TN, Queitsch C. Thousands of high-quality sequencing samples fail to show meaningful correlation between 5S and 45S ribosomal DNA arrays in humans. Sci Rep. 2021 Jan 11;11(1):449. doi: 10.1038/s41598-020-80049-y. PMID: 33432083; PMCID: PMC7801704.
- Hori Y, Shimamoto A, Kobayashi T. The human ribosomal DNA array is composed of highly homogenized tandem clusters. Genome Res. 2021 Nov;31(11):1971-1982. doi: 10.1101/gr.275838.121. Epub 2021 Aug 18. PMID: 34407983; PMCID: PMC8559705
- Konkova MS, Ershova ES, Savinova EA, Malinovskaya EM, Shmarina GV, Martynov AV, Veiko RV, Zakharova NV, Umriukhin P, Kostyuk GP, Izhevskaya VL, Kutsev SI, Veiko NN, Kostyuk SV. 1Q12 loci movement in the interphase nucleus under the action of ROS is an important component of the mechanism that determines copy number variation of satellite Ⅲ(1q12) in health and schizophrenia. Front Cell Dev Biol. 2020 Jun 5;8:386. doi: 10.3389/fcell.2020.00386. PMID: 32714923; PMCID: PMC7346584.
- Ershova ES, Savinova EA, Kameneva LV, Porokhovnik LN, Veiko RV, Salimova TA, Izhevskaya VL, Kutsev SI, Veiko NN, Kostyuk SV. Antipsychotics affect satellite Ⅲ(1q12) copy number variations in the cultured human skin fibroblasts. Int J Mol Sci. 2023 Jul 10;24(14):11283. doi: 10.3390/ijms241411283. PMID: 37511043; PMCID: PMC10380077.